KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Asset Writedowns and Impairment (2017 - 2025)

Labcorp Holdings' Asset Writedowns and Impairment history spans 7 years, with the latest figure at $2.8 million for Q4 2024.

  • For Q4 2024, Asset Writedowns and Impairment fell 99.16% year-over-year to $2.8 million; the TTM value through Jun 2025 reached $2.8 million, down 99.19%, while the annual FY2025 figure was $4.3 million, 18.87% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2024 was $2.8 million at Labcorp Holdings, up from $2.5 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $437.4 million in Q1 2020 and bottomed at $1.2 million in Q4 2020.
  • The 4-year median for Asset Writedowns and Impairment is $2.8 million (2023), against an average of $98.0 million.
  • The largest annual shift saw Asset Writedowns and Impairment skyrocketed 83.33% in 2023 before it plummeted 99.16% in 2024.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at $1.2 million in 2020, then surged by 21608.33% to $260.5 million in 2022, then increased by 28.14% to $333.8 million in 2023, then tumbled by 99.16% to $2.8 million in 2024.
  • Per Business Quant, the three most recent readings for LH's Asset Writedowns and Impairment are $2.8 million (Q4 2024), $2.5 million (Q1 2024), and $333.8 million (Q4 2023).